Alembic Ltd.
| BSE: 506235 | Sector: Health care |
| NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
| BSE 12:07 | 28 Sep | 115.20 |
-0.25 (-0.22%) |
OPEN
114.75 |
HIGH
116.00 |
LOW
114.35 |
| NSE 11:59 | 28 Sep | 115.05 |
-0.45 (-0.39%) |
OPEN
116.00 |
HIGH
116.10 |
LOW
114.60 |
| OPEN | 114.75 |
| PREVIOUS CLOSE | 115.45 |
| VOLUME | 29590 |
| 52-Week high | 143.30 |
| 52-Week low | 83.00 |
| P/E | 195.25 |
| Mkt Cap.(Rs cr) | 2,958 |
| Buy Price | 115.10 |
| Buy Qty | 1.00 |
| Sell Price | 115.20 |
| Sell Qty | 1.00 |
Alembic Ltd. (ALEMBICLTD) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 724.90 | 2.75 | 0.38 | 15823.68 |
| Cipla | 959.00 | -3.35 | -0.35 | 13900.58 |
| Dr Reddy's Labs | 4758.20 | -30.55 | -0.64 | 13349.10 |
| Sun Pharma.Inds. | 761.95 | -1.00 | -0.13 | 12803.21 |
| Lupin | 934.05 | -2.30 | -0.25 | 11055.93 |
| Apollo Hospitals | 4474.00 | -91.75 | -2.01 | 9153.00 |
| Cadila Health. | 542.90 | -14.20 | -2.55 | 7790.40 |
| Glenmark Pharma. | 496.90 | -6.85 | -1.36 | 7567.93 |
| Alkem Lab | 3943.20 | -57.45 | -1.44 | 7219.68 |
| Divi's Lab. | 4800.05 | -133.45 | -2.70 | 6798.61 |
| Torrent Pharma. | 3068.65 | -20.45 | -0.66 | 6450.83 |
| Ipca Labs. | 2351.90 | -20.45 | -0.86 | 5114.11 |
| Alembic Pharma | 788.70 | 0.05 | 0.01 | 5051.44 |
| Laurus Labs | 591.65 | -8.10 | -1.35 | 4768.72 |
| Abbott India | 21319.95 | 141.30 | 0.67 | 4310.02 |
| Gland Pharma | 3830.30 | -14.90 | -0.39 | 3462.88 |
| Glaxosmi. Pharma | 1486.95 | -2.25 | -0.15 | 3193.74 |
| Granules India | 317.95 | -1.15 | -0.36 | 3134.98 |
| Sanofi India | 7878.15 | -72.25 | -0.91 | 2901.90 |
| Ajanta Pharma | 2209.75 | 31.40 | 1.44 | 2718.59 |
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
